RLD-2302
- Generic Name
- RLD-2302
A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 66
- Registration Number
- NCT06518122
- Locations
- 🇰🇷
Jeonbuk National University Hospital, Jeonju, Jeollabuk-do, Korea, Republic of
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
- First Posted Date
- 2024-04-10
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 34
- Registration Number
- NCT06357910
- Locations
- 🇰🇷
Jeonbuk University Hospital, Jeonju, Jeollabuk-do, Korea, Republic of
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers
- First Posted Date
- 2024-04-03
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 37
- Registration Number
- NCT06346184
- Locations
- 🇰🇷
Jeonbuk University Hospital, Jeonju, Jeollabuk-do, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath